A small trial found that 82% of patients receiving high-dose niacin alongside standard glioblastoma treatment remained progression-free after six months, suggesting the vitamin may help revive immune cells suppressed by the cancer.
High-Dose Vitamin B3 Shows Early Promise Against Glioblastoma
A small trial found that 82% of patients receiving high-dose niacin alongside standard glioblastoma treatment remained progression-free after six months, suggesting the vitamin may help revive immune cells suppressed by the cancer.
Leptomeningeal cancer · Wikimedia — licence per file · rights
This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.
Monitoring item. The full text is not distributed. Extract and source below.